Steven Lichtman

Stock Analyst at Oppenheimer

(1.55)
# 1664
Out of 5,218 analysts
74
Total ratings
48.89%
Success rate
20.97%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
DexCom
Maintains: Outperform
115 105
77.21 35.99% 8 Oct 25, 2024
Zimmer Biomet Holdin...
Maintains: Outperform
145 135
106.86 26.33% 7 Oct 15, 2024
MannKind
Maintains: Outperform
10 12
6.54 83.49% 2 Aug 28, 2024
Alcon
Maintains: Outperform
103 110
84.14 30.73% 3 Aug 22, 2024
Medtronic
Maintains: Perform
92 94
82.47 13.98% 10 Aug 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
72 65
37.21 74.68% 8 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
47 58
32.68 77.48% 1 Jun 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
10 11
9.46 16.28% 5 May 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
12
8.97 33.78% 2 Apr 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
82 87
102.83 -15.39% 1 Feb 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
58 68
90.16 -24.58% 2 Feb 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
4
1.61 117.39% 2 Sep 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 9 May 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
300 275
269.59 2.01% 3 Jan 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
273 288
375.05 -23.21% 1 Jul 28, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
105
139.11 -24.52% 3 Jul 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Perform
150
24.87 503.14% 1 Jul 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Perform
83 85
94.91 -10.44% 2 Sep 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Dec 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Perform
n/a
n/a n/a 2 Apr 12, 2017